IDXX
IDEXX Laboratories, Inc.
Stock
$518.39+0.64 (+0.12%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.4B | $1.2B | $929M | $907M | $543M | $756M | $648M | $459M | $400M | $373M | $339M | $222M | $236M | $246M | $222M | $218M | $179M | $175M | $143M |
| Capital expenditures | $117M | $125M | $121M | $134M | $149M | $120M | $107M | $155M | $116M | $74M | $65M | $83M | $61M | $78M | $58M | $50M | $39M | $51M | $90M |
| Free cash flow | $1.3B | $1.1B | $808M | $773M | $394M | $636M | $541M | $304M | $284M | $299M | $274M | $139M | $175M | $168M | $165M | $168M | $140M | $124M | $53M |
| Stock-based compensation | $63M | $60M | $60M | $60M | $50M | $38M | $31M | $39M | $25M | $24M | $20M | $20M | $18M | $17M | $16M | $15M | $13M | $12M | $11M |
| Buybacks | $1.2B | $1.2B | $837M | $72M | $820M | $747M | $183M | $302M | $369M | $283M | $304M | $402M | $618M | $368M | $132M | $256M | $143M | $83M | $132M |
| Free cash flow margin | 27.5% | 24.6% | 20.7% | 21.1% | 11.7% | 19.8% | 20.0% | 12.6% | 12.8% | 15.2% | 15.4% | 8.7% | 11.8% | 12.2% | 12.7% | 13.8% | 12.7% | 12.0% | 5.2% |